openPR Logo
Press release

Wearable Continuous Glucose Monitor (CGM) Market is Set to Experience a Revolutionary Growth

05-12-2025 01:37 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Wearable Continuous Glucose Monitor

Wearable Continuous Glucose Monitor

As of 2024, the global market value for wearable continuous glucose monitors (CGMs) is estimated at $4.8 billion, driven by increasing prevalence of diabetes and the growing demand for real-time health monitoring devices. The market is projected to reach approximately $10.5 billion by 2034, representing a substantial growth trajectory. This projection indicates a compound annual growth rate (CAGR) of about 8.2% during the forecast period of 2025 to 2034.

Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Wearable Continuous Glucose Monitor (CGM) market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Wearable Continuous Glucose Monitor (CGM) market.

This report is also available in the following languages : Japanese (ウェアラブル持続血糖モニター (CGM)), Korean (웨어러블 연속 혈당 모니터(CGM)), Chinese (穿戴式连续血糖监测仪 (CGM)), French (Moniteur de glycémie continu portable (CGM)), German (Tragbarer kontinuierlicher Glukosemonitor (CGM)), and Italian (Monitor continuo del glucosio indossabile (CGM)), etc.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/59644

Key Companies:
Dexcom Inc., Abbott Laboratories, Medtronic Plc, Senseonics Holdings Inc., Glooko Inc., Eversense, FreeStyle Libre, LivaNova Plc, Roche Diabetes Care, Tandem Diabetes Care, Bigfoot Biomedical, Insulet Corporation, Ascensia Diabetes Care, Nova Biomedical, Diasend

Market Segmentation
By Product Type
Transcutaneous CGM
Implantable CGM
Professional CGM

By Application
Diabetes Management
Sports and Fitness Monitoring
Clinical Research

By End User
Hospitals
Homecare Settings
Diabetes Clinics

By Technology
Bluetooth Enabled
Smartphone Compatible
Cloud-Based

By Distribution Channel
Online Retail
Pharmacies
Medical Supply Stores

Explore Full Report here: https://exactitudeconsultancy.com/reports/59644/global-wearable-continuous-glucose-monitor-cgm-market

If opting for the Global version of Wearable Continuous Glucose Monitor (CGM) Market; then the below country analysis would be included:

- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)

Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=59644

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Wearable Continuous Glucose Monitor (CGM) market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Wearable Continuous Glucose Monitor (CGM) market.

Get Your Exclusive Offer with up to 30% Discount : https://exactitudeconsultancy.com/check-discount/59644

Reasons To Buy The Wearable Continuous Glucose Monitor (CGM) Market Report:

➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods

Our team is available 24/7 to assist and support our customers through reliable research.

Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.

Other Reports:

https://smb.windsorweekly.com/article/Automotive-Suspension-System-Market-Size-Worth-7562-Billion-by-2030-or-Latest-Report-by-Exactitude-Consultancy?storyId=667d3449abafe09975c6973a

https://www.openpr.com/news/4008209/multipurpose-medical-chairs-market-growth-demand-price#:~:text=The%20global%20multipurpose%20medical%20chairs,2034%20is%20estimated%20at%205.2%25.

https://pr.columbiabusinessmonthly.com/article/3D-Semiconductor-Packaging-Market-Outlook-Report-2024-or-Report-which-provides-an-in-depth-analysis-Based-on-Regions-Applications-Exactitude-Consultancy?storyId=6699175a709b0518e4154d75

https://smb.roanoke-chowannewsherald.com/article/3D-Modeling-Market-is-expected-to-be-valued-at-USD-1332-billion-by-2033-or-Exactitude-Consultancy?storyId=66a35d09709b0518e43db646

https://cnes.einnews.com/pr_news/731294842/rf-probe-card-market-is-expected-to-be-valued-at-usd-4-360-97-million-by-2033-exactitude-consultancy

https://www.togobusinesspost.com/article/731888178-photolithography-market-is-expected-to-be-valued-at-usd-12-99-billion-by-2030-exactitude-consultancy

https://www.asiapacificherald.com/article/733994989-microencapsulated-pesticides-market-is-expected-to-be-valued-at-usd-671-76-billion-by-2033-exactitude-consultancy

https://sse.einnews.com/pr_news/736775084/air-fryer-market-is-expected-to-be-valued-at-usd-2-84-billion-by-2033-exactitude-consultancy

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Wearable Continuous Glucose Monitor (CGM) Market is Set to Experience a Revolutionary Growth here

News-ID: 4010904 • Views:

More Releases from Exactitude Consultancy

Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 billion by 2034
Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 b …
Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and blood. Despite advances in frontline therapies, relapse is common, and many patients develop refractory disease, leaving limited treatment options and poor survival outcomes. Relapsed/refractory AML (R/R AML) remains a major unmet clinical need. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71571 In recent years, however, the
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around 3% of all childhood cancers but is the most common intraocular malignancy in children. With improved awareness, early screening, and advances in treatment, survival rates in developed nations exceed 90%. However, challenges remain in low- and middle-income countries where delayed diagnosis and limited access to
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Lymphoma, a group of blood cancers affecting the lymphatic system, is broadly classified into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). While survival outcomes have improved significantly with chemotherapy, radiotherapy, targeted agents, and immunotherapies, many patients experience severe toxicities as side effects of treatment. These toxicities - ranging from cytokine release syndrome (CRS) and neurotoxicity in CAR-T therapy to myelosuppression, infections, and organ toxicities from chemotherapy and immunomodulators - can
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft tissue neoplasms are abnormal growths arising from connective tissues, including muscles, fat, nerves, tendons, and blood vessels. While some are benign, malignant forms such as soft tissue sarcomas (STS) pose serious clinical challenges due to their aggressive nature, rarity, and diverse histological subtypes. Representing about 1% of all adult cancers, these neoplasms require a wide spectrum of treatments ranging from surgery and radiotherapy to chemotherapy and novel targeted therapies. Download

All 5 Releases


More Releases for CGM

Universal Adhesive Patch For CGM And Insulin Pump
Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days Waterproof & Reinforced Defense - Pair it with your CGM Blood Glucose Monitoring Sensor [https://www.uwtapes.com/uw-adhesive-patch/] or TruSteel Infusion Kit while showering, bathing, exercising or swimming without worry. Protect your CGM sensor from collisions. Compatible with CGM sensors and insulin pumps [https://www.uwtapes.com/uw-adhesive-patch/] - ideal for users of closed loop systems. Suitable for
Global BGM and CGM Market Research Report 2023-2029
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose. Continuous glucose monitoring automatically tracks blood glucose levels,
Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention. In 2017, National Diabetes Services Scheme (NDSS) initiated by
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
CMA CGM S. A. - Company Strategy & Performance Analysis
The research report presents a comprehensive assessment of the CMA CGM S. A. and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. Purchase the Report at (USD $499 only): https://www.marketinsightsreports.com/report/purchase/0926871550?mode=su?source=openpr&Mode=12                   CMA CGM
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market. The global CGM market is undergoing a